ArticleCancers2022

Treatment of RET-Positive Advanced Medullary Thyroid Cancer with Multi-Tyrosine Kinase Inhibitors-A Retrospective Multi-Center Registry Analysis.

Viktoria Florentine Koehler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.